An inactivated vaccine as an aid in the control of swine erysipelas, for the protection of embryos and foetuses against porcine parvovirus infection and for the reduction of infection caused by Leptospira serovars. This product may only be prescribed by your veterinary practitioner from whom advice must be sought.
Product information for Veterinary Healthcare Professionals
Porcilis Ery+Parvo+Lepto is an inactivated vaccine containing Erysipelothrix rhusiopathiae antigen, serotype 2 (strain M2), Porcine parvovirus strain 014), Leptospira interrogans serogroup Canicola serovar Portland-Vere (strain Ca-12-00), Leptospira interrogans serogroup Icterohaemorrhagiae serovars Copenhageni (strain lc-02-001), Leptospira interrogans serogroup Australis serovars Bratislava (strain As-05-073), Leptospira kirschneri serogroup Grippotyphosa serovars Dadas (strain Gr-01-005), Leptospira interrogans serogroup Pomona serovar Pomona (strain Po-01-000) and Leptospira santarosai serogroup Tarrasovi serovars Gatuni (strain S1148/02).
The vaccine also contains 150 mg dl-α tocopherol per dose.
The vaccine is for the active immunisation of sows and gilts as an aid in the control of swine erysipelas, for the protection of embryos and foetuses against porcine parvovirus infection and for the reduction of infection caused by Leptospirosis serovars.
For uses, dosage, contra-indications and warnings please consult product leaflet. Further information is available on request.
Use medicines responsibly.
Multidose vials containing 10 or 25 doses
Summary of Product Characteristics
For Summary of Product Characteristics, first click on this link. Then type in Porcilis Ery+Parvo+Lepto in Product name field. Click on Run search. Subsequently click on View SPC on line listing opposite Porcilis Ery+Parvo+Lepto.